Literature DB >> 18158562

Prognostic significance of loss of c-fos protein in gastric carcinoma.

Seon Pil Jin1, Ji Hun Kim, Min A Kim, Han-Kwang Yang, Hee Eun Lee, Hye Seung Lee, Woo Ho Kim.   

Abstract

c-fos was first identified as a viral oncoprotein, and has been studied in terms of its oncogenic function in tumorigenesis. Many experimental and clinical data indicated that c-fos expression plays a role in the progression of several types of carcinomas. However, some recent studies challenge this view as they indicate that c-fos has tumor suppressor activity. In the present study, we assessed c-fos protein expression in 625 consecutive gastric cancers immunohistochemically, and analyzed its relationship with clinicopathologic factors and survival. We found that a loss of c-fos expression is correlated with a more advanced stage, lymph node metastasis, lymphatic invasion and shorter survival, indicating that c-fos expression in gastric cancer cells is lost during progression and that this loss is associated with a poor prognosis. The above findings suggest that loss of c-fos expression has tumor suppressor activity in gastric cancer and we suspect that this suppressor activity might be related to the pro-apoptotic function of c-fos.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158562     DOI: 10.1007/bf02940306

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  30 in total

1.  Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas.

Authors:  D J Papachristou; A Batistatou; G P Sykiotis; I Varakis; A G Papavassiliou
Journal:  Bone       Date:  2003-04       Impact factor: 4.398

2.  Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas.

Authors:  K Wakita; H Ohyanagi; K Yamamoto; T Tokuhisa; Y Saitoh
Journal:  Int J Pancreatol       Date:  1992-02

3.  AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun.

Authors:  C Grimm; A Wenzel; A Behrens; F Hafezi; E F Wagner; C E Remé
Journal:  Cell Death Differ       Date:  2001-08       Impact factor: 15.828

4.  Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.

Authors:  M F Yuen; P C Wu; V C Lai; J Y Lau; C L Lai
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

5.  Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation.

Authors:  S Willaime; P Vanhoutte; J Caboche; Y Lemaigre-Dubreuil; J Mariani; B Brugg
Journal:  Eur J Neurosci       Date:  2001-06       Impact factor: 3.386

6.  Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.

Authors:  D Siegmund; D Mauri; N Peters; P Juo; M Thome; M Reichwein; J Blenis; P Scheurich; J Tschopp; H Wajant
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

7.  DNA fragmentation and Prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase.

Authors:  T Kondo; F R Sharp; J Honkaniemi; S Mikawa; C J Epstein; P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  1997-03       Impact factor: 6.200

8.  Role of DNA 5-methylcytosine transferase in cell transformation by fos.

Authors:  A V Bakin; T Curran
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

9.  c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities.

Authors:  T D Halazonetis; K Georgopoulos; M E Greenberg; P Leder
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

10.  Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton.

Authors:  A Franchi; A Calzolari; G Zampi
Journal:  Virchows Arch       Date:  1998-06       Impact factor: 4.064

View more
  15 in total

1.  c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.

Authors:  Stefano Sioletic; Jeffrey Czaplinski; Lan Hu; Jonathan A Fletcher; Christopher D M Fletcher; Andrew J Wagner; Massimo Loda; George D Demetri; Ewa T Sicinska; Eric L Snyder
Journal:  J Pathol       Date:  2014-08-01       Impact factor: 7.996

Review 2.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

3.  Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice.

Authors:  Manoj K Pandey; Guangming Liu; Timothy K Cooper; Kathleen M Mulder
Journal:  Int J Cancer       Date:  2011-04-08       Impact factor: 7.396

4.  Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer.

Authors:  Jun-Chao Guo; Jian Li; Yu-Pei Zhao; Li Zhou; Quan-Cai Cui; Wei-Xun Zhou; Tai-Ping Zhang; Lei You
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

5.  Regression analysis of combined gene expression regulation in acute myeloid leukemia.

Authors:  Yue Li; Minggao Liang; Zhaolei Zhang
Journal:  PLoS Comput Biol       Date:  2014-10-23       Impact factor: 4.475

6.  c-Fos over-expression promotes radioresistance and predicts poor prognosis in malignant glioma.

Authors:  Zhi-Gang Liu; Guanmin Jiang; Jiao Tang; Hui Wang; Guokai Feng; Furong Chen; Ziwei Tu; Guiyun Liu; Yu Zhao; Ming-Jing Peng; Zheng-Wen He; Xiao-Yan Chen; Holly Lindsay; Yun-Fei Xia; Xiao-Nan Li
Journal:  Oncotarget       Date:  2016-10-04

7.  C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.

Authors:  S Mahner; C Baasch; J Schwarz; S Hein; L Wölber; F Jänicke; K Milde-Langosch
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

8.  Tumor Restrictive Suicide Gene Therapy for Glioma Controlled by the FOS Promoter.

Authors:  Jianqing Pan; Hao Wang; Xinmin Liu; Jiliang Hu; Weijian Song; Jie Luo; Shan Jiang; Fei Yan; Baojin Zhai
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

9.  c-FOS suppresses ovarian cancer progression by changing adhesion.

Authors:  L Oliveira-Ferrer; K Rößler; V Haustein; C Schröder; D Wicklein; D Maltseva; N Khaustova; T Samatov; A Tonevitsky; S Mahner; F Jänicke; U Schumacher; K Milde-Langosch
Journal:  Br J Cancer       Date:  2013-12-05       Impact factor: 7.640

10.  Identifying gastric cancer related genes using the shortest path algorithm and protein-protein interaction network.

Authors:  Yang Jiang; Yang Shu; Ying Shi; Li-Peng Li; Fei Yuan; Hui Ren
Journal:  Biomed Res Int       Date:  2014-03-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.